相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma
Hui Jia et al.
FRONTIERS IN GENETICS (2023)
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma
Larissa Haertle et al.
CANCERS (2023)
The Gentle Side of the UPS: Ubiquitin-Proteasome System and the Regulation of the Myogenic Program
Hugo C. Olguin
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity
Yunjian Fan et al.
DISEASE MARKERS (2022)
Modulating the Ubiquitin-Proteasome System: A Therapeutic Strategy for Autoimmune Diseases
Dhananjay Yadav et al.
CELLS (2022)
19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML)
Joshua J. Lara et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
Daniel Bottomly et al.
CANCER CELL (2022)
Evaluating the Prognostic and Therapeutic Potentials of the Proteasome 26S Subunit, ATPase (PSMC) Family of Genes in Lung Adenocarcinoma: A Database Mining Approach
Md. Asad Ullah et al.
FRONTIERS IN GENETICS (2022)
Proteomics analysis of cancer tissues identifies IGF2R as a potential therapeutic target in laryngeal carcinoma
Bing Liu et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma
Kira Allmeroth et al.
LEUKEMIA (2021)
The molecular and cellular insight into the toxicology of bortezomib-induced peripheral neuropathy
Wenping Yan et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13
Yan Song et al.
BLOOD CANCER JOURNAL (2021)
The Ubiquitin-Proteasome System in Immune Cells
Gonca cetin et al.
BIOMOLECULES (2021)
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B
Alfonso E. Bencomo-Alvarez et al.
ONCOGENE (2021)
Efficacy and Toxicity Profile of Carfilzomib-Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review
Hassaan Imtiaz et al.
OncoTargets and Therapy (2021)
Mechanisms of substrate recognition by the 26S proteasome
Caroline Davis et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2021)
Novel Insight Into the Association Between Obesity and Hepatocellular Carcinoma Occurrence and Recurrence: High-Throughput Microarray Data Set Analysis of Differentially Expressed Genes
Seyedeh Faezeh Hassani et al.
JCO CLINICAL CANCER INFORMATICS (2021)
Prognoses and genomic analyses of proteasome 26S subunit, ATPase (PSMC) family genes in clinical breast cancer
Tzu-Jen Kao et al.
Aging-US (2021)
26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy
Andres J. Rubio et al.
CELLS (2021)
Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Group
Richard Aplenc et al.
HAEMATOLOGICA (2020)
Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling
Ruey-Shyang Soong et al.
BMC CANCER (2020)
Drug Development Targeting the Ubiquitin-Proteasome System (UPS) for the Treatment of Human Cancers
Xiaonan Zhang et al.
CANCERS (2020)
A novel risk score system of immune genes associated with prognosis in endometrial cancer
Hongyu Zhou et al.
CANCER CELL INTERNATIONAL (2020)
Impact of Losing hRpn13 Pru or UCHL5 on Proteasome Clearance of Ubiquitinated Proteins and RA190 Cytotoxicity
Vasty Osei-Amponsa et al.
MOLECULAR AND CELLULAR BIOLOGY (2020)
Proteasome Subunits Differentially Control Myeloma Cell Viability and Proteasome Inhibitor Sensitivity
Chang-Xin Shi et al.
MOLECULAR CANCER RESEARCH (2020)
Proteasome, a Promising Therapeutic Target for Multiple Diseases Beyond Cancer
Yu Cao et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
Cankun Zhou et al.
CANCER CELL INTERNATIONAL (2020)
Phosphorylation of Tyr-950 in the proteasome scaffolding protein RPN2 modulates its interaction with the ubiquitin receptor RPN13
Casey W. Hemmis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myeloma
Yan Song et al.
LEUKEMIA (2019)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
Carfilzomib for relapsed and refractory multiple myeloma
K. Groen et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Proteasome 26S Subunit, non-ATPase 3 (PSMD3) Regulates Breast Cancer by Stabilizing HER2 from Degradation
Abdulfattah Salah Fararjeh et al.
CANCERS (2019)
Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression
Sourav Banerjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Dynamic Regulation of the 26S Proteasome: From Synthesis to Degradation
Richard S. Marshall et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2019)
Proteasome 26S subunit PSMD1 regulates breast cancer cell growth through p53 protein degradation
Toshiyuki Okumura et al.
JOURNAL OF BIOCHEMISTRY (2018)
RA190, a Proteasome Subunit ADRM1 Inhibitor, Suppresses Intrahepatic Cholangiocarcinoma by Inducing NF-κB-Mediated Cell Apoptosis
Guang-Yang Yu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer
Bradleigh Whitton et al.
CANCER MEDICINE (2018)
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W. Tyner et al.
NATURE (2018)
Structure and energetics of pairwise interactions between proteasome subunits RPN2, RPN13, and ubiquitin clarify a substrate recruitment mechanism
Ryan T. VanderLinden et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets
Xiuxiu Lu et al.
NATURE COMMUNICATIONS (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
(Immuno)proteasomes as therapeutic target in acute leukemia
Jacqueline Cloos et al.
CANCER AND METASTASIS REVIEWS (2017)
The Logic of the 26S Proteasome
Galen Andrew Collins et al.
CELL (2017)
Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis
Xing Guo et al.
NATURE CELL BIOLOGY (2016)
Targeting the 19S proteasomal subunit, Rpt4, for the treatment of colon cancer
Karen Boland et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Targeting proteasome ubiquitin receptor Rpn13 in multiple myeloma
Y. Song et al.
LEUKEMIA (2016)
Deubiquitinase inhibition as a cancer therapeutic strategy
Padraig D'Arcy et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome
Peter Tsvetkov et al.
ELIFE (2015)
Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System
Q. Ping Dou et al.
CURRENT CANCER DRUG TARGETS (2014)
A novel role for the proteasomal chaperone PSMD9 and hnRNPA1 in enhancing IκBα degradation and NF-κB activation - functional relevance of predicted PDZ domain-motif interaction
Indrajit Sahu et al.
FEBS JOURNAL (2014)
TRAP1 role in endoplasmic reticulum stress protection favors resistance to anthracyclins in breast carcinoma cells
Lorenza Sisinni et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Regulated protein turnover: snapshots of the proteasome in action
Sucharita Bhattacharyya et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
DNA damage emergency: cellular garbage disposal to the rescue?
H. R. Stone et al.
ONCOGENE (2014)
Structural Biology of the Proteasome
Erik Kish-Trier et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 42 (2013)
Structural Insights into Proteasome Activation by the 19S Regulatory Particle
Aaron Ehlinger et al.
BIOCHEMISTRY (2013)
A bis-Benzylidine Piperidone Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 as a Therapy for Cancer
Ravi K. Anchoori et al.
CANCER CELL (2013)
Functions of the 19S complex in proteasomal degradation
Chang-Wei Liu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins
M. R. Amoroso et al.
CELL DEATH AND DIFFERENTIATION (2012)
Complete subunit architecture of the proteasome regulatory particle
Gabriel C. Lander et al.
NATURE (2012)
Molecular architecture of the 26S proteasome holocomplex determined by an integrative approach
Keren Lasker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Bortezomib: Understanding the Mechanism of Action
Bilal Piperdi et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma
O. J. C. Hellwinkel et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2011)
Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome
Daniel Finley
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
P-type ATPases as drug targets: Tools for medicine and science
Laure Yatime et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2009)
Damage control: DNA repair, transcription, and the ubiquitin-proteasome system
Anne Daulny et al.
DNA REPAIR (2009)
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)
A. Arlt et al.
ONCOGENE (2009)
The proteasome: Overview of structure and functions
Keiji Tanaka
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2009)
Molecular basis of bortezomib resistance:: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
Ruud Oerlemans et al.
BLOOD (2008)
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP:: tipping the scales of cancer
David Frescas et al.
NATURE REVIEWS CANCER (2008)
Acid suppression therapy: Where do we go from here?
Carmelo Scarpignato et al.
DIGESTIVE DISEASES (2006)
Ubiquitin: structures, functions, mechanisms
CM Pickart et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
分享论文
